West Caldwell, NJ, United States of America

Norman Kong



 

Average Co-Inventor Count = 6.0

ph-index = 5

Forward Citations = 217(Granted Patents)


Location History:

  • West Caldwell, NJ (US) (2001 - 2012)
  • Beijing, CN (2016 - 2018)
  • Jiangsu, CN (2018)

Company Filing History:


Years Active: 2001-2018

Loading Chart...
Loading Chart...
Loading Chart...
21 patents (USPTO):

Title: Innovator Spotlight: Norman Kong - Pioneering JAK Inhibitor Technology

Introduction:

Norman Kong, a prolific inventor based in West Caldwell, NJ, has made significant contributions to the field of pharmaceuticals with a remarkable portfolio of 21 patents. His cutting-edge work focuses on the development of Janus kinase (JAK) inhibitors for the treatment of various conditions such as rheumatoid arthritis, asthma, COPD, and cancer.

Latest Patents:

Kong's latest patents showcase his innovative approach to JAK inhibitor technology. The first patent highlights the synthesis of Ethyl N-boc piperidinyl pyrazolo pyridones as potent JAK inhibitors, offering a promising avenue for treating JAK-mediated diseases. The second patent introduces Acyclic cyanoethylpyrazolo pyridones as JAK inhibitors, further expanding the repertoire of compounds for combating these debilitating conditions.

Career Highlights:

Having worked at prestigious pharmaceutical companies like Hoffmann-La Roche Inc. and Merck Sharp & Dohme Corporation, Norman Kong has honed his expertise in drug discovery and development. His groundbreaking research has earned him recognition as a leading figure in the pharmaceutical industry, particularly in the field of JAK inhibitors.

Collaborations:

Throughout his career, Kong has collaborated with esteemed professionals in the field, including Nicholas J S Huby and John Anthony Moliterni. Together, they have synergized their talents to drive forward innovation in pharmaceuticals and pave the way for novel treatment modalities.

Conclusion:

Norman Kong's dedication to advancing JAK inhibitor technology underscores his commitment to improving patient outcomes and addressing unmet medical needs. His remarkable contributions to the field of pharmaceuticals continue to inspire future generations of inventors and researchers. Norman Kong stands as a beacon of innovation, driving progress in the fight against JAK-mediated diseases.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…